Next article

The US Department of Health and Human Services releases its widely anticipated comprehensive plan for addressing high drug prices

On September 9, 2021, the Department of Health and Human Services ("HHS") released its widely anticipated "Comprehensive Plan for Addressing High Drug Prices." The HHS report supports far-reaching legislative and administrative actions. These include changes that would allow the government to negotiate drug prices, limit price increases to the rate of inflation, prohibit "pay-for-delay" agreements, expedite generic and biosimilar drug approvals, restructure cost sharing and reimbursements in Medicare, and tether Medicare payments to patient outcomes. HHS's proposed initiatives would have substantial impacts not only on drug prices, but also on innovation and antitrust policy relevant to the pharmaceutical industry. The HHS report comes in response to President Biden's July 9, 2021

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Authors

Quotation

Eugene Hutchinson, Michael Gallagher, The US Department of Health and Human Services releases its widely anticipated comprehensive plan for addressing high drug prices, 9 September 2021, e-Competitions September 2021, Art. N° 105883

Visites 218

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues